Locations:
Search IconSearch

News & Insight

church bus tour
December 9, 2025/Cancer/News & Insight

Novel Community Campaign Increases Venous Thromboembolism Awareness

National Blood Clot Alliance collaborates with faith-based organizations on first-of-its-kind church bus tour

Dr. Gerds
December 8, 2025/Cancer/News & Insight

AI Screening Platform Accelerates Trial Recruitment in Polycythemia Vera

AI-driven tools can streamline enrollment and improve efficiency across clinical trials.

Dr. Abraham
November 26, 2025/Cancer/News & Insight

Artificial Intelligence in Oncology (Podcast)

Real-world applications in clinical documentation and trial matching

Patient holding loved one's hand
November 7, 2025/Cancer/News & Insight

Facing Fear: How to Help Patients Navigate Cancer Anxiety

Psychosocial oncology offers a path forward

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Jame Abraham
October 20, 2025/Cancer/News & Insight

Trastuzumab Deruxtecan Improves Invasive Disease-Free Survival of Early-Stage HER+ Breast Cancer by 53%

International study supports change in clinical care in post-neoadjuvant setting

Physician comforting patient
August 12, 2025/Cancer/News & Insight

Resilience Matters: Mental Wellness Tied to Higher Immunotherapy Success in Advanced Non-Small Cell Lung Cancer

Cleveland Clinic psychiatrist urges integrating psychosocial care into oncology

Surgeon
June 30, 2025/Cancer/News & Insight

Potential for Deintensification of Surgical Interventions in Low-Risk Breast Cancer

Reconsidering axillary lymph node dissection as well as depth of surgical margins

Dendritic cell
June 26, 2025/Cancer/News & Insight

Avelumab Induces Natural Killer Cell Activation and Dendritic Cell Crosstalk

Researchers uncover profound differences in the mechanism of action between different PD-L1 checkpoint inhibitors

BackPage 1 of 9Next

Advertisement

Ad